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GAD is characterised as a chronic condition, with a DSM-V diagnosis
typically requiring the persistent symptomof excessiveworry occurring
over a period of 6 months (American Psychiatric Association, 2013).
Further symptoms consist of hypervigilance and the typical somatic
responses of anxiety, where the chronicity of these symptoms often
results in long-term personal suffering and feelings of a loss of control
(Wittchen, 2002). European statistics place the lifetime prevalence of
GAD to be between 4.3 and 5.9% and a 12-month prevalence to be
between 1.2 and 1.9% (Wittchen, 2000). However, a signiﬁcant amount
of individuals do not seek treatment for their disorder (Wittchen et al.,
2011). GAD tends to present itself with comorbidity, most often withy College Dublin, Ireland.
. This is an open access article undermood and other anxiety disorders (Alonso et al., 2004; Royal College
of Psychiatrists, 2011). Furthermore, negative effects can extend from
the direct effects the disorder has on the individual; economic, personal
and social roles can be negatively impacted upon by symptoms of GAD,
which in turn can decrease quality of life (Loebach Wetherell et al.,
2004; Stein and Heimberg, 2004).
1.1. Anxiety and students
Several studies have examined the link between anxiety symptom-
atology and university students (Royal College of Psychiatrists, 2011).
Major life events, such as the transition to university life and the respon-
sibilities that comewith it can be a large source of anxiety. Furthermore,
societal trends such as the increasing ﬁnancial cost of university places
extra burden on students, where they often have to source employment
in order to fund their college lives (Royal College of Psychiatrists, 2011).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fitzgerald (2012) in their survey of mental health and wellbeing in an
Irish sample. Utilising an Irish student-based sample, the researchers
placed levels of anxiety at 36% and 30% with symptoms of stress.
Although this research did not include data on GAD in students
speciﬁcally.
1.2. Treating anxiety disorders
Treatment of anxiety disorders, and more speciﬁcally GAD, has
largely consisted of pharmacological treatments, psychological thera-
pies or a mixture of both (Gould et al., 1997). However, completion
and cessation of a pharmacological therapy without continuing to take
maintenance drugs can result in relapse (Davidson et al., 2008;
Allgulander et al., 2006). Psychological therapies are often preferred,
especiallywhere they have produced similar outcomes to pharmacolog-
ical treatments, along with lower relapse rates (Sturmey and Hersen,
2012).
Cognitive-behaviour therapy (CBT) is routinely chosen as the
psychological treatment of choice for GAD, and has been subject to
several successful trials (Cuijpers et al., 2014). CBT for GAD is composed
of many elements, such as cognitive restructuring, worry exposure,
mindfulness, relaxation techniques and information on the disorder
(Dugas et al., 2003; Orsillo et al., 2003). CBT for GAD can be performed
in either a group or one-to-one setting, where the therapist helps the
patient to understand their disorder, manage it and regain quality of
life. However, it has been estimated that across the anxiety disorders a
large percentage do not seek treatment, or have a signiﬁcant delay in
receiving treatment (Kohn et al., 2004). One signiﬁcant barrier is the
ability to access evidence-based treatments such as CBT. Internet-
delivered CBT (iCBT) interventions are a relatively new development
that could help with increasing access to treatments.
1.3. iCBT for GAD
Several studies have investigated the effectiveness of iCBT for GAD
and results have shown positive outcomes in regards to post-
treatment and follow-up symptom relief (Titov et al., 2009, 2011;
Paxling et al., 2011). Internet-delivered psychological interventions for
GAD are a promising new intervention with a growing evidence base.
Results from research trials are evidencing large effect sizes that can
be sustained up to 2/3 years post-treatment (Titov et al., 2016). Prelim-
inary results are encouraging, and speak to the potential of using thera-
pist, or self-guided iCBT for GAD (Titov et al., 2016).
Richards et al. (2015a) conducted a systematic review and meta-
analysis of internet-delivered psychological interventions for the
treatment of GAD. Studies recruited primarily through websites and/
or adverts in local newspapers; some used clinical samples referred
from GPs or mental health practitioners. All studies used the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I; First et al., 1997),
the Mini International Neuropsychiatric Interview Version 5.0.0 (MINI;
Sheehan et al., 1998), or an interview based on the MINI (Johansson
et al., 2013) to establish a formal diagnosis of GAD, over the phone or
in person. Four of the eleven studies targeted a GAD sample through a
GAD-speciﬁc programme; the other seven were “transdiagnostic” in
nature, addressing multiple anxiety disorders or GAD and mood
disorders. Most studies (9/11) used CBT-based content while two
used a psychodynamic approach. Generally, content was delivered in
6–8 modules over 8–10 weeks; most interventions also included some
form of support from a psychologist or therapist, typically by phone or
e-mail.
There were statistically signiﬁcant improvements for internet-
delivered interventions compared to waiting-list controls on self-
reported GAD symptoms (d = −0.91) and pathological worry
(d = −0.74), both yielding what can be considered large effects
(Cohen, 1988). Similar effects were found for the active treatmentscompared to waiting-list controls for comorbid anxiety (d =−0.57),
depression (d = −0.63), distress (d = −0.91), disability
(d = −0.77), and quality of life (d = 0.38). For GAD subjects, effect
sizes were similar for GAD-speciﬁc (d = −0.81) and transdiagnostic
(d = −0.91) interventions. Psychodynamic approaches (2 studies)
had less favourable results; in fact, one study (Andersson et al., 2012)
saw an unexpected improvement in the waiting list group. The authors
advised caution in interpreting these results given limited and heterog-
enous data, and suggested what research is needed to strengthen the
ﬁeld.
The current study aimed to implement an iCBT (Calming Anxiety) for
GAD. Based on previous literature in the area of online interventions for
GAD (Richards et al., 2015a), it was hypothesised that the intervention
would produce signiﬁcant decreases in GAD symptoms at post-inter-
vention for the treatment group compared to the control group.
2. Methods
2.1. Design
The current study utilised a service-based effectiveness, randomised
controlled trial design in order to examine the delivery of an internet in-
tervention for the treatment of individuals with GAD symptoms. The
trial was registered (Current Controlled Trials ISRCTN16303842) and
the protocol published (Richards et al., 2014). Participants were
randomised into two groups using: the internet-delivered intervention
(iCBT, Calming Anxiety) with clinical support and a waiting list control
group. Randomisation was achieved using a computer algorithm
established by a programmer and independently executed. The
randomisation took place at the individual level using a 1:1 format for
distribution between the groups. Participants in the waiting list control
group did not receive any treatment for the 6-week duration in which
the treatment group was receiving the intervention. At week 7, partici-
pants in thewaiting list control groupwere given access to the support-
ed intervention. The current paper describes the main outcomes from
the trail. Other research data related to this trial including quality of
life, satisfaction with treatment and signiﬁcant events data are being
analysed and will be reported elsewhere (see trial protocol for details;
Richards et al., 2014).
Ethical approval for the current study was obtained from the
appropriate University Ethics Committee (25/11/2013). Prior to
commencing the study, all participants received information that
detailed the intervention in its entirety. Informed consent was then
obtained and participants were made aware that their involvement
was completely voluntary and that they were free to withdraw from
the study at any stage without prejudice.
2.2. Participants and sample size
Participants for the current study were recruited through the
University counselling service and were all registered students.
Participants were contacted via e-mail (delivered college wide) in
order to advertise the current study and request their participation.
This e-mail detailed how the prospective participant could obtain
further information and initiate the screening process. This e-mail was
sent to all students two times at an interval of two weeks during the
ﬁrst three weeks of the second academic semester.
Primary eligibility criteria for participation in the studywas based on
whether the individual's self-reported GAD symptoms were conﬁrmed
to reach an acceptable clinical threshold, deﬁned for the study as a
score of 10 or above on theGAD-7measure. Further criteria for inclusion
in the study were that participants were to be at least 18 years of age or
older. Participants attending face-to-face counselling were excluded
from the study. In order to target the trial as closely as possible to a
GAD population, severe depressionwas used as a criterion for excluding
possible comorbidities (BDI II scores N29). Suicidal ideation was also
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client group seeking online support (score of 1 or higher on BDI II item
9). It was deemed unethical to include clients experiencing suicidal ide-
ation for an online intervention without any face-to-face needs
assessment. The study recruited and screened N = 324, 187 were
excluded and 137 were included into the RCT and randomised
(Treatment n= 70, Waiting List n= 67).
2.3. The intervention
The Calming Anxiety supported programme was delivered to
participants over the course of the 6 week intervention, where each
week participants completed an online CBT-based interventionmodule
for GAD. The programme structure and content were based on CBT
concepts and strategies and included cognitive, emotional and behav-
ioural components such as self-monitoring, relaxation, cognitive
restructuring and worry outcome monitoring (Behar et al., 2009).
The intervention was delivered on a web 2.0 platform using interac-
tive content. Eachmodulewas identically structured, where introducto-
ry quizzes, videos, informational content, interactive content activities
and homework suggestions formed a part of each module. Personal
stories and accounts from other clients were also incorporated into
the programme and this was presented to participants as a text piece
or video. Further details on the individual models are presented in
Table 1.
Because thiswas a naturalistic study and student userswere encour-
aged to complete one module per week for the duration of six weeks,
this was not guaranteed. It is the case that students progressed through
the intervention as they would normally through service offered by the
counselling centre, that is, they could pause their participation at any
time, they did not necessarily adhere strictly to the one module per
week, and many keep using the intervention after the initial 6-week
period.
A key function of the supporters was to monitor participant
progress, helping participants who chose to do more than one module
per week to get the most out of each module, and encouraging
participants who worked slower through the intervention to ﬁnd the
most suitable content for their needs. Many participants continued to
use the intervention after the 6-week treatment period.
Participants could access all modules at once, and could complete
them in any order. There were nomandatory aspects of the programme
– all reading and homework tasks were suggested, but not required to
progress through the programme. Participants could also choose to
share the content from exercises with supporters so that they were
free to complete them without having to discuss them if this was
preferable.
If participants did not engage with content for two weeks in a row,
supporters wrote a review that let participants know their account
was “paused” – a new review date was set if and when participants
chose to log back in. The system sent automatic e-mails to encourageTable 1
Module descriptors.
Module name Brief description
Getting Started Outlines the basic premise of CBT
their current difﬁculties with anx
Understanding Moods and Emotions This module describes the behavi
The user is introduced to relaxatio
Anxious thoughts and worry This module focuses on noticing a
acceptance, distraction, and ‘worr
Face your Anxiety, Step by Step This module outlines why avoidan
Users are encouraged to build the
Challenge your Anxious Thoughts This module explains negative au
encouraged to challenge the thou
Bringing it all Together In this ﬁnal module, users are enc
their personal warning signs, andparticipants to log back in and use the programme. Usage statistics
and feedback from supporters indicate that a proportion of participants
signed up to the programme, but did not access any of the
psychoeducational content, had their accounts paused, and did not log
back in (except to complete time 2 data).
2.4. Supporters
Upon commencing treatment, participants were assigned a support-
er to monitor their performance throughout the 6-week intervention.
There were six supporters involved in the trial. All supporters were
psychologists with a master's degree or higher. The training for sup-
porters consisted of ﬁrst working through the entire Calming Anxiety
programme as a user. Additionally, 4 h of training followed on how to
write messages and how to screen user content for disclosures of risk.
All supporters receivedweekly supervision regarding their work within
the trial. Each week, supporters logged in and evaluated the work
completed by participants spending10–15 min providing feedback to
each participant at a scheduled time. All feedback was sent to
participants through the Calming Anxietymessaging system.
Participants were assigned to a speciﬁc supporter, based on avail-
ability, who followed their progress throughout their time using the
programme to ensure continuity of care. Supporters provided limited
information about themselves through a “proﬁle”, where they chose
whether to include a proﬁle picture and a brief summary of who they
were. Supporters had a guide to help them give feedback. They could
choose how closely they based their responses to participants on the
examples given, as long as their feedback conformed with the
psychoeducational content of the programme, and was responsive to
any homework content shared by participants or messages sent to
them.On the reviewday, supporterswere able to seewhat pages of con-
tent participants had accessed, their ratings of different modules, and
whether participants had commented on pages, created journal entries,
or used certain activities. Supporters could only see the content of com-
ments and activities if the participant chose to “share” these with them.
Supporters could also see any messages left for them by participants.
2.5. Risk management
Upon signing into the hosting platform for theﬁrst time and creating
their user account, participantswere presentedwith a user contract that
detailed Calming Anxiety and the study in its entirety. This user contract
also stated that Calming Anxiety does not provide emergency support
and that if at any stage a participant feels a change in their wellbeing,
they should contact their general practitioner or a clinician at the
counselling service. Further to this, Calming Anxiety also provided a
page with information about speciﬁc services the individual could
contact in this case. Upon digitally signing this user contract, partici-
pants were assumed to understand the information that was presented
to them.and provides some information about anxiety. Users are encouraged to explore
iety and to begin monitoring their anxiety levels.
oural, physical, and emotional aspects of the Thoughts-Feelings-Behavior (TFB) cycle.
n practices. Users start to build their own anxiety-related TFB cycles.
nxious thoughts and worry, and ways of relating to these thoughts, including
y time’.
ce is harmful, and breaks down the steps needed for successful graded exposure.
ir own fear hierarchies and to begin working through them.
tomatic thoughts, their role in anxiety, and how to challenge them. Users are
ghts in their TFB cycles, and make use of helpful thoughts.
ouraged to bring together all the skills and ideas they have gathered so far, note
make a plan for staying well.
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ments below, they were “ﬂagged up” by the system if they scored 29 or
more on the BeckDepression Inventory (BDI-II) and/or indicated suicid-
al ideation in the relevant item. Students were informed that they were
temporarily not able to complete sign-up because of their scores; the
message also stated that they would be contacted within a working
day, and referred to emergency services. A member of the counselling
team then contacted the student to arrange a face-to-face or phone
meeting. Of those excluded from the study, they were offered other
appropriate sources of support.2.6. Assessments
2.6.1. Socio-demographic data
The Sociodemographic & Clinical History questionnaire was based
on that used in an earlier study (Richards et al., 2013), and was
developed to collect demographic and clinical details of the participants.
To this extent, the questionnaire accounts for any existing diagnosis of
anxiety disorders and the length of time that participants had experi-
enced anxiety symptoms. It collected data on participant's experience
of counselling, therapy, and medication for anxiety, and on whether
participants had any existing diagnoses of mental health disorders. In
addition, it contained items related to comorbid psychosis, alcohol and
drug misuse, and/or any recent medical diagnosis.2.6.2. Primary outcomes measure
The primary outcomemeasure for the current study was the Gener-
alized Anxiety Disorder 7 (GAD-7; Spitzer et al., 2006) that comprises 7
items measuring symptoms and severity of GAD based on the DSM-IV
diagnostic criteria for GAD. The GAD-7 has good internal consistency
(α = 0.89) and convergent validity with other anxiety scales
(Kroenke et al., 2010). Higher scores indicate greater severity of symp-
toms. The GAD-7 has increasingly been used in large-scale studies as a
generic measure of change in anxiety symptomatology (Richards and
Suckling, 2009). Using the threshold score of 10, the GAD-7 has a
sensitivity of 89% and a speciﬁcity of 82% for GAD; it is considered
congruent with DSM-IV as a clinical case for GAD (Spitzer et al., 2006).2.6.3. Secondary outcomes measures
The Work and Social Adjustment (WASA; Mundt et al., 2002) is a
simple, reliable and valid measure of impaired functioning. It is a 5-
item self-report measure which provides an experiential impact of a
disorder from the patient's point of view. The measure looks at how
the disorder impairs the patient's ability to function in day to day life
on ﬁve dimensions: work, social life, home life, private life and close
relationships.
The Beck Depression Inventory 2nd edition (BDI II; Beck et al., 1996)
assesses depressive symptoms that correspond to the criteria for a de-
pressive disorder diagnosis as outline in the DSM-IV (American
Psychiatric Association [APA], 2000). The scale designates four levels
of severity; minimal (0 to 13), mild (14 to 19), moderate (20 to 28)
and severe (29 to 63) (Beck et al., 1996). The scale has demonstrated
good convergent validitywith othermeasures of depression across clin-
ical and nonclinical adult samples (Beck et al., 1988).
The Penn State Worry Questionnaire (PSWQ) (Meyer et al., 1990)
consists of 16 items and is considered a valid clinical measure of the
worry characteristic of GAD. Each item is measured on a 5-point Likert
scale (1 – not at all typical of me to 5 – very typical of me) and a total
score ranging between 0 and 80 is calculated by summing all items. Psy-
chometric evaluations have revealed a high internal consistency (α=
0.86 to 0.95) and test-retest reliability over four weeks (r = 0.74 to
0.93; Molina and Borkovec, 1994). The measure has been found to
successfully differentiate between patients with GAD and those with
other anxiety disorders (Brown et al., 1992).2.7. Data analysis
The analysis of themain outcomemeasure (GAD-7)was based on an
intention-to-treat principle, where data from those who began treat-
ment and provided subsequent data were included in the data set irre-
spective of treatment compliance. Last observation carried forward
(LOCF) was initially proposed to handle missing data where it occurred.
However, expectation maximisation (EM; Dempster et al., 1977) was
chosen over LOCF to be implemented. EMwas implemented formissing
data using SPSS 21. As amethod for handlingmissing data, it is an acces-
sible procedure that generates a single imputation of data for analysis.
Originally, data analysis was planned to span across three time
points – pre, post and 3 month follow-up. However, participant
response for the third time point in regards to both the treatment and
waiting list group returned minimal numbers (n = 24: 21 in the
treatment group, 3 in the waiting list group). As such, this time point
was omitted due to lack of valid data available for analysis and due to
risk of biasing the imputation procedure.
In order to test the main hypotheses, repeated measures ANOVA
were proposed to be performed in the trial protocol. However, on
further examination of the data analysis procedure, and based on
reviewers comments, it was decided that univariate analyses of co-
variance (ANCOVA) would be performed, using pre-treatment scores
as covariance in each respective analysis. Within group differences
were analysed using paired samples t-tests. Participants were then
compared across groups and time points. Effect sizes were established
using Cohen's d statistic (Cohen, 1988).
Following the main analyses, pre and post scores were examined in
order to estimate the percentage of participants who made a clinically
meaningful change at the end of treatment. An estimation of remission
was made using data from those who scored above the established
clinical cut offs at pre measurement and compared with their post
data in order to examine whether they scored below the clinical cut-
off (GAD-7 cut-off b10, BDI-II cut-off b14, PSWQ cut-off b45, WASA
cut-off b10). Estimates of reliable recovery were made by identifying
the number of participants in each group who demonstrated a 50%
pre-treatment reduction of GAD-7, BDI-II and PSWQ scores.
3. Results
3.1. Baseline characteristics
Three hundred and twenty-four students were recruited and
screened for eligibility and of those 137 were randomised to either the
initial or delayed treatment groups. Chi square tests revealed that at
post-randomisation there were no signiﬁcant differences on any vari-
ables between the treatment group and waiting list control group.
Fig. 1 shows the participant ﬂow through the trial and the reasons for
exclusion. Participants (N = 137) were predominately female (77%),
with a mean age of 23.82 (S.D. = 7.05) and the age range was
17–58 years. Participant characteristics are presented in Table 2.
3.2. Treatment response rate
As per the treatment protocol participantswere offered 7modules of
content to complete. Participants were encouraged to progress through
in a linear fashion, but were not excluded from using the modules as
they choose. Treatment response is a difﬁcult concept in online as it
seems that individuals' progression through content in various ways
can all lead to positive outcomes (Richards et al., 2015b). Graph 1
displays the adherence to the modules as a simple understanding of
adherence in online interventions. Of those who began the intervention
N50% completed 5 modules of content and almost 25% completed all 7
modules. The average number of logons was 8.31 and the average
amount of time spent per session was 27.38 min.
Assessed for Eligibility
(N = 324)
Randomized
(n = 137)
Excluded (n = 187), reasons for 
exclusion:
Incomplete data, n = 1
High BDI-II score, n = 15
Pre GAD-7 score <10, n = 171
Allocated to active intervention 
(n = 70)
Allocated to waiting list control 
(n = 67)
Post-treatment data (n = 59)
Included in ITT analysis (n = 70)
Post-treatment data (n = 53)
Included in ITT analysis (n = 67)
Fig. 1. Flowchart of the study CONSORT.
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As per the published protocol (Richards et al., 2014), analyses were
conducted on the data using participants with a cut-off of ≥10 on
GAD-7 scores. The means, standard deviations and effect sizes (d)
associated with all outcome measures for each group and between
groups are presented in Table 2. Correcting for multiple testing, a
conservative p criteria of b0.01 was applied to both paired samples t-
tests and ANCOVA.
Paired samples t-test for GAD-7 scores conducted on the treatment
and waiting-list control group showed signiﬁcant within group
differences between pre and post time points, t(1, 69) = 10.2, p ≤ 0.01
and t(1, 66) = 6.72, p ≤ 0.01 respectively. Univariate ANCOVA
procedures on post-treatment GAD-7 scores, using pre-treatment
scores as a covariate, showed no signiﬁcant difference in generalized
anxiety disorder symptoms between the treatment and control group,
F(1, 134) = 3.20, p= 0.076.
Using paired samples t-tests, signiﬁcant within group differences
from pre to post time points on the BDI-II and WASA were observed.
No signiﬁcant within groups differences, in either the treatment or
control group, were observed for PSWQ scores from pre-post time
points. These results are summarised and presented in Table 3.
Univariate ANCOVAs were also carried out for secondary outcome
measures, using pre-treatment scores as a covariate. No signiﬁcant
difference was found between treatment and control groups for PSWQ
worry scores, F(1, 134) = 1.03, p= 0.311. Signiﬁcant differences were
found for both BDI-II and WASA, F(1, 134) = 7.02, p ≤ 0.01 and, F(1,
134) = 8.35, p ≤ 0.01 respectively. Table 4 illustrates a summary ofthe ANCOVA results, including between groups effect sizes (Cohen's d)
with 95% conﬁdence intervals.
3.4. Clinically signiﬁcant change
As previously discussed, clinically signiﬁcant change was deﬁned in
two ways. First, an estimation of remission was established using the
criteria for a cut-off of below10onGAD-7. Using this cut-off in the treat-
ment group, we observed remission of anxiety symptoms in 53 (75%)
participants in the treatment group compared to 40 (59%) participants
in the waiting list control group. When correcting for multiple testing,
chi squared analyses showed no signiﬁcant difference between the
two groups in terms of cases of remission, Χ2 (1, N = 137) = 4.03,
p = 0.045. Second, we deﬁned recovery as a 50% reduction in pre to
post scores on the GAD-7. In the treatment group, we observed this
change in 33 subjects (47.1%) compared to 23 (34%) subjects in the
waiting list control group. Further chi squared analyses found no
differences between groups exhibiting a 50% reduction in symptoms
as per the GAD-7, X2 (1, N = 137) = 2.33, p = 0.13. Cut-off data are
presented in Table 5.
The number needed to treat (NNT) for a client to reach recovery
from the treatment was calculated at 8 individuals and for remission
this number would be 6 (Cook and Sackett, 1995; Wen et al., 2005).
4. Discussion
The current study sought to investigate the effectiveness of the
internet-delivered iCBT Calming Anxiety programme as a low-intensity
Table 2
Demographic and clinical characteristics.
Treatment Waiting list Total sample
(n = 70) (n = 67) (N = 137)
Variable Sub-variable n % n % n %
Gender Male 18 25.7 13 19.4 31 22.6
Female 52 74.3 54 80.6 106 77.4
Age Mean age (SD) 23.19 (6.17) 23.24 (6.38) 23.82 (7.05)
Range 18–45 17–58 17–58
Employment status Working 32 45.7 24 35.8 56 40.9
Not working 38 54.3 43 64.2 81 59.1
Civil status Have a partner 14 20 20 29.9 34 24.8
Married 3 4.3 1 1.5 4 2.9
Separated 0 1.3 1 1.5 1 0.7
Divorced 1 1.4 4 6 5 3.6
Single 49 70 38 56.7 87 63.5
Other 3 4.3 3 4.5 6 4.4
Previous diagnosis of anxiety disorder Yes 13 18.6 10 14.9 23 16.8
No 57 81.4 57 85.1 114 83.2
Time with symptoms b6 months 7 10 9 13.4 16 11.7
6 months–
2 years
21 30 21 31.3 42 30.7
2–5 years 21 30 20 29.9 41 29.9
5+ years 21 30 17 25.4 38 27.7
Previous therapy for anxiety Yes 26 37.1 21 31.3 47 34.3
No 44 62.9 46 68.7 90 65.7
Previous medication for anxiety Yes 13 18.6 11 16.4 24 17.5
No 57 81.4 56 83.6 113 82.5
Current medication for anxiety Yes 6 8.6 3 4.5 9 6.6
No 64 91.4 64 95.5 128 93.4
IT conﬁdence Very conﬁdent 45 64.3 38 56.7 83 60.6
Conﬁdent 22 31.4 17 25.4 39 28.5
Average 3 4.3 9 13.4 12 8.8
Mildly conﬁdent 0 0 3 4.5 3 2.2
Not conﬁdent 0 0 0 0 0 0
85D. Richards et al. / Internet Interventions 6 (2016) 80–88intervention for the treatment of general anxiety disorder symptoms in
a student population. Data analysis highlighted a main effect of time,
where participants in both groups (including wait-list) displayed a
reduction in GAD symptoms from pre to post measurement. Analysis
of the secondary outcomes indicated similar results for the PSWQ.
Contrary to our expectations we did not show a signiﬁcant between
group effects for the main outcome on anxiety.
Other studies of similar design and topic to that of the current piece
of research have demonstrated statistically signiﬁcant between group
differences (Paxling et al., 2011; Titov et al., 2009; Robinson et al.,
2010). All three studies included support elements, much like theGraph 1. Adherence to mcurrent study, and speciﬁcally featured iCBT interventions targeted at
GAD, as opposed to transdiagnostic approaches. In these studies, the im-
provements in the waiting list groups, when quantiﬁed in terms of
Cohen's d, were much smaller than those of the present study (Paxling
et al., 2011, d = 0.18; Titov et al., 2009, d = 0.34; Robinson et al.,
2010, d = 0.36). From an analysis of recent literature, the current
study can be seen to contradict normative results in the ﬁeld, such
that the control group improved signiﬁcantly in comparison to the
active treatment group. Therefore, the results of the current study can
be viewed as unusual. Below, several possible explanations for these
results are provided.odules over time.
Table 3
Results of paired samples t-tests for within group differences across time points, includingM, SD,M differences and effect sizes.
Measure Group Pre Post t-Test Pre-post Effect size
n M (SD) M (SD) Paired samples M difference (95% CI) d (95% CI)
GAD 7 Treatment 70 12.84 (2.39) 7.73 (4.44) t(1, 69) = 10.21, p ≤ 0.01 5.11 (4.11–6.11) 1.5 (0.94–2.54)
Control 67 13.19 (2.78) 9.13 (4.13) t(1, 66) = 6.72, p ≤ 0.01 4.06 (2.85–5.27) 1.18 (0.51–2.16)
BDI-II Treatment 70 17.67 (6.44) 14.54 (8.07) t(1, 69) = 3.26, p ≤ 0.01 3.12 (1.22–5.03) 0.43 (−1.08–2.32)
Control 67 17.67 (5.41) 18.1 (8.99) t(1, 66) = −0.42, p ≥ 0.05 −0.43 (−2.51–1.64) −0.06 (−1.36–2.09)
PSWQ Treatment 70 63.04 (8.11) 58.53 (10.97) t(1, 69) = 3.69, p ≤ 0.01 4.51 (2.08–6.95) 0.47 (−1.43–3.04)
Control 67 63.48 (6.95) 60.33 (8.79) t(1, 66) = 3.25, p ≤ 0.01 3.15 (1.21–5.08) 0.4 (−1.26–2.5)
WASA Treatment 70 11.93 (6.39) 9.69 (6.16) t(1, 69) = 2.83, p ≤ 0.01 2.24 (0.66–3.82) 0.36 (−1.14–1.8)
Control 67 14.48 (6.31) 13.34 (5.75) t(1, 66) = 1.25, p ≥ 0.05 1.13 (−0.684–2.95) 0.19 (−1.32–1.56)
Note. GAD-7: Generalized Anxiety Disorder 7; BDI-II: BeckDepression Inventory, 2nd edition; PSWQ: Penn StateWorry Questionnaire;WASA:Work and Social Adjustment questionnaire.
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participants of the initial 324 in the current study were recruited in
January. During this period in the university where the trial occurred,
winter examinations take place over the course of several weeks. It is
plausible that the symptoms of GAD experienced at baseline may have
been inﬂated due to academic pressures and did not accurately reﬂect
normal manifestations of the disorder. However, at post-treatment
data collection and following exams and the subsequent decrease in
workload, stress and anxiety levels may have decreased, thus reducing
GAD symptoms across the entire sample.
The overall decreasing trend in self-reported symptoms of depres-
sion in the treatment group suggests that the intervention demonstrat-
ed some potential not only addressing anxiety and worry, but the
comorbid depressive symptoms so closely related to anxiety disorders
in general. In addition the signiﬁcant changes noted for participants
on the WASA is a positive indication of improvement especially given
the deleterious effects mental illness can have upon work and social
functioning (LoebachWetherell et al., 2004; Stein andHeimberg, 2004).
A point of interest in the discussion is that the current intervention
was shorter than typical internet-delivered interventions for GAD and
the time to complete was generally shorter too (Andersson et al.,
2012; Berger et al., 2014; Paxling et al., 2011; Titov et al., 2011). This
may be suggestive that ﬁrst the intervention itself may require
tweeking and second that its format for delivery may need to be
different in natural settings.
The result also leaves us with some questions about the entire
project and some of these we would like to consider further. Treatment
expectancies have been found to play a signiﬁcant role in the outcomes
of psychological therapies (Dozois and Westra, 2005), where positive
expectancies of therapy have been found to produce more positive
outcomes (Snyder et al., 2000). The current study utilised a waiting
list control where participants were administered psychometric
measures and informed they would be receiving treatment after a
short period of time. Through promotional materials for the study or
through self-sought information about cognitive behavioural therapy,
participants in the waiting list may have held positive expectations forTable 4
Results from ANCOVA, with baseline scores as covariate.
Measure ANCOVA d (95% CI)
GAD 7 F(1, 134) = 3.20,
p ≥ 0.05
0.3 (−0.07–1.3)
PSWQ F(1, 134) = 1.03,
p ≥ 0.05
0.18 (−1.92–2.23)
BDI-II F(1, 134) = 7.02,
p ≤ 0.01
0.46 (−1.43–2.3)
WASA F(1, 134) = 8.35,
p ≤ 0.01
0.36 (−1–1.69)
Note. GAD-7: Generalized Anxiety Disorder 7; BDI-II: Beck Depression Inventory, 2nd
edition; PSWQ: Penn State Worry Questionnaire; WASA: Work and Social Adjustment
questionnaire.the therapy they would receive. The increase in scores, may in itself,
have been the product of a quasi-placebo effect. In addition to these
considerations is the further possibility that students in the current
studymay have accessed additional treatments or interventions during
their participation in the research whichmay have impacted on results.
This was not explicitly controlled for in this study.
A number of other factors may have confounded the results of the
current study. Due to the naturalistic setting of the research, the study
was constricted to the use of a single measure of anxiety, the GAD-7,
rather than a battery of anxiety measures. GAD, however, is one of the
most difﬁcult psychological disorders to diagnose accurately (Brown
et al., 2001a). Despite revisions to the diagnostic criteria of GAD since
its addition to the DSM in 1980 (DSM-III), it continues to demonstrate
lower reliability than other disorders (Brown et al., 2001b). Inherent
in the criteria of GAD include issues pertaining to criteria that overlap
with aspects of other disorders and vagueness of the criteria; diagnosis
relies on subjective report of internal processes and lacks behavioural
markers (Brown et al., 2001a, 2001b; Robichaud, 2013). Moreover, the
evolving nature of theGAD construct has somewhat impeded the devel-
opment of research, theory and appropriate measures (Holaway et al.,
2006; Turk and Wolanin, 2006). By using this as the primary outcome
measure we may not have been accurately capturing the mechanisms
of change that the programme was facilitating but were rather looking
for speciﬁc GAD symptomology in a populationwhowere not routinely
receiving diagnoses of disorders butwere instead experiencing general-
ized anxiety in more individualised ways.
Follow-upwas largely unsuccessful in the current study. Again aswe
were implementing the trial in a natural setting we were not permitted
to engage in a robust follow-up protocol, therefore any post treatment
data that was collected was due mainly to a follow-up email requesting
participants to complete that data; further confounded by time at
follow-up which was holiday period for most students. The result was
a very small follow-up data that we decided not to include in the
analysis.Table 5
Participants above and below the designated cut-off scores from pre to post.
Treatment
(n = 70)
Waiting list
(n = 67)
Total sample
(N = 137)
Above Below Above Below Above Below
GAD-7 Pre 70 0 67 0 137 0
Post 17 53 27 40 44 93
BDI Pre 53 17 56 11 109 28
Post 41 29 51 16 92 45
PSWQ Pre 70 0 66 1 136 1
Post 62 8 64 3 126 11
WASA Pre 43 27 55 12 98 39
Post 37 33 53 14 90 47
Note. Cut-off scores applied: GAD-7 cut-off b10, BDI-II cut-off b14, PSWQ cut-off b45,
WASA cut-off b10.
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Given the above difﬁculties, it can be proposed that these may have
had a number of implications for the current study in terms of both
measurement and intervention. The use of the GAD-7may have proved
limiting and problematic in several respects. Firstly, while this measure
has been demonstrated to be congruent with the DSM-IV, only one
study has examined and reported this congruency (Spitzer et al.,
2006). This study utilised a relatively older student sample (mean age
23), posing questions about the generalisability of such results to the
student population in the current research. Furthermore, the current
study adopted the cut-off point of GAD-7 score ≥10 used in the
congruency study, to indicate the presence of GAD. Healthcare services
within the UK (NHS; IAPT services) and related research projects (e.g.
Clark et al., 2009), however, use a GAD-7 cut-off point of ≥8 to indicate
caseness; future research in naturalistic settings might then be
recommended to follow suit using a cut-point as applied in practice.
Indeed our analysis would show signiﬁcant movement from caseness
to non-caseness under these criteria.
These difﬁculties inherent in the accurate assessment and measure-
ment of GAD thus raise questions about the nature of the population
who participated in this research. Whether the students identiﬁed in
this study were indeed a homogeneous group of adults who met the
appropriate criteria for GAD (i.e. a GAD speciﬁc population) or a mixed
group presenting with various anxiety related symptoms appears un-
clear and presents as a substantial limitation to this study. Given that
the current intervention was targeted speciﬁcally at GAD, one could
speculatewhether treatment effectswere concealed by this possible het-
erogeneity. Future research would recommend use of a wider range of
assessment measures to enable increased accuracy of GAD identiﬁcation
and avoid the occurrence of false positives, as a single measure such as
the GAD-7 is insufﬁcient. Indeed, the GAD-7 only captures respondents'
answers froma twoweek time periodwhereas formal diagnosis requires
an evaluation that considers a period of six months minimum. Further-
more, given the difﬁculty of GAD assessment, some researchers have
put forward the suggestion that a diagnosis of GAD should ideally be
conﬁrmed by two separate assessment interviews (Borkovec and
Costello, 1993; Brown et al., 2001b). Such recommendations, however,
may be difﬁcult to implement in naturalistic research settings.
This trial puts forward two main suggestions for the design of a trial
concerning iCBT and GAD. Firstly, when utilising a university sample
and targeting an illness of a speciﬁc nature, dates for the implementa-
tion of interventions and symptom recording/assessment should be
scheduled appropriately. A large number of participants in the current
study (206 out of 324) were recruited and assessed during the winter
examination period. This may have had an effect on initial anxiety
scores in both groups, where individuals presented with inﬂated anxi-
ety during exams, and then both groups returned to sub-threshold
scores post examinations. This may also serve as a valid explanation
for the absence of interaction effects in the current study.
The second recommendation is informed by a further limitation of
the study. As we are unable to determinewhether participants accessed
other treatments during the study periodwe could not control for this in
the analysis, but it may be a factor of some importance in explaining the
results. Future research in naturalistic setting should plan for recording
what other, if any, treatments or supports that students might engage
with that could potentially impact on outcomes. For instance, in addi-
tion to counselling and psychological interventions some universities
have learning and academic supports for students and these may have
a positive impact on anxiety symptoms if they are related to academic
stressors.
4.2. Conclusion
The current study reports a main effect of time, but no between
group differences following an internet-delivered intervention targetedat GAD in college students. In light of the potential difﬁculties inherent
in the concept, measurement and nature of GAD, it seems reasonable
to question whether a number of confounding factors related to these
may have masked potential effects of the intervention. Other aspects
that may have confounded the potential of the intervention include
the implementation of the intervention, the time required to complete
the intervention and the fact that the intervention content itself may
beneﬁt from appropriate revision. This study highlights some further
considerations for implementing and researching iCBT interventions
in naturalistic settings.
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